Idorsia conducts clinical trials globally to advance our studies. Our key assets have the potential to transform treatment in the target indications.
Currently, we support Idorsia activities and clinical studies out of the following locations:
Our locations
Idorsia Pharmaceuticals Ltd
Headquarters of Idorsia Ltd and is responsible for drug discovery, development, registration, production, quality assurance, safety, and Idorsia management and coordination.
Idorsia Pharmaceuticals Deutschland GmbH
Based in Lörrach, Germany and performs clinical development on behalf of Idorsia and acts as Idorsia's representative for obtaining regulatory approvals in the EU.
Idorsia Pharmaceuticals US Inc.
Based in New Jersey, US and performs clinical development on behalf of Idorsia.
Idorsia (Shanghai) Pharmaceuticals Co. Ltd
Based in Shanghai, PRC and performs research and development on behalf of Idorsia.
Idorsia Pharmaceuticals Japan Ltd
Based in Tokyo, Japan and performs clinical development on behalf of Idorsia.
Vaxxilon Ltd
A majority-owned subsidiary of Idorsia Ltd, based in Reinach/BL, Switzerland and performs research and development activities.